Cutaneous adverse reactions following anti-infective vaccinations

American Journal of Clinical Dermatology

Volumn 6, Issue 2, 2005, Pages 79-87

  Nikkels, Arjen F ^a,b   Nikkels Tassoudji, Nazli ^b   Piérard, Gerald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Dermatology Division   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CETIRIZINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS VACCINE; HEPATITIS A HEPATITIS B VACCINE; INFLUENZA VACCINE; ISONIAZID; MENINGOCOCCUS VACCINE; MUTAGRIP S; ORAL POLIOMYELITIS VACCINE; POLIO SABIN ORAL; POLIOMYELITIS VACCINE; RIFAMPICIN; TWINRIX JUNIOR;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ATOPIC DERMATITIS; BCG VACCINATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIPHTHERIA; ERYTHEMA; FEMALE; GRANULOMATOSIS; HEPATITIS A; HEPATITIS B; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFANT; INFLUENZA; INFLUENZA VACCINATION; MALE; MENINGOCOCCOSIS; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN ALLERGY; SKIN MANIFESTATION; SKIN SCAR; SKIN TUBERCULOSIS; TETANUS; VACCINATION REACTION;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; FEMALE; HUMANS; INFANT; MALE; VACCINES;

EID: 17244364234     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200506020-00002     Document Type: Review

References (120)

1. Ponvert C, Scheinmann P. Vaccine allergy and pseudo-allergy. Eur J Dermatol 2003; 13: 10-5
2. Ovetchkine P. Effets secondaires des vaccinations. Arch Pediatr 2001; 8: 316-20
3. Usman A, Kimyai-Asadi A, Stiller MJ, et al. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol 2001; 18: 123-6
4. Schupp P, Vente C. Lichen planus following hepatitis B vaccination. Int J Dermatol 1999; 38: 799-800
5. Ferrando MF, Doutre MS, Beylot-Barry M, et al. Lichen planus following hepatitis B vaccination [letter]. Br J Dermatol 1998; 139: 350
6. Aubin F, Angonin R, Humbert P, et al. Lichen planus following hepatitis B vaccination. Arch Dermatol 1994; 130: 1329-30
7. Ciaccio E, Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? [letter]. Br J Dermatol 1990; 122: 424
8. Trevisan G, Stinco G. Lichen ruber planus following HBV vaccination [letter]. Acta Derm Venereol 1993; 73: 73
9. Trevisan G, Stinco G. HBV vaccination and lichen planus. G Ital Dermatol Venereol 1993; 128: 545-8
10. Lefort A, Dachary D, Vergier B, et al. Lichen plan et vaccination anti hépatite B. Ann Dermatol Venereol 1995; 122: 701-3
11. Saywell CA, Wittal RA, Kossard S. Lichenoid reaction to hepatitis B vaccination. Aust J Dermatol 1997; 38: 152-4
12. Tessari G, Barba A, Schena D. Lichen ruber planus following the administration of human anti-hepatitis B virus immunoglobulins. Acta Derm Venereol 1996; 76: 1564-74
13. Rybojad M, Moraillon I, Laglenne S, et al. Lichen plan de l'enfant: 12 cas. Ann Dermatol Venereol 1998; 125: 679-81
14. Dalton SJ, Haeney MR, Patel L, et al. Exacerbation of atopic dermatitis after bacillus Calmette-Guerin vaccination. J R Soc Med 1998; 91: 133-4
15. Kumagai T, Yamanaka T, Wataya Y, et al. A strong association between HLA-DR9 and gelatin allergy in the Japanese population. Vaccine 2001; 19: 3273-6
16. Elgart GW, Hanly A, Busso M, et al. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy. J Am Acad Dermatol 1999; 40: 315-7
17. Hazelrigg DE. Basal cell epithelioma in a vaccination scar. Int J Dermatol 1978; 17: 723-5
18. Panizzon R. Basal cell epithelioma in a BCG vaccination scar [letter]. Arch Dermatol 1980; 116: 381
19. Lanzafame S, Micali G. Cutaneous lymphoid hyperplasia (pseudolymphoma) secondary to vaccination. Pathologica 1993; 85: 555-61
20. Cotterill JA, Shapiro H. Dermatomyositis after immunisation. Lancet 1978; II: 1158-9
21. Ehrengut W. Dermatomyositis and vaccination. Lancet 1978; I: 1040-1
22. Tay YK. Gianotti-Crosti syndrome following immunization [letter]. Pediatr Dermatol 2001; 18: 262
23. Lugosi L. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology: a review. Tuber Lung Dis 1992; 73: 252-61
24. Antaya RJ, Gardner ES, Bettencourt MS, et al. Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 2001; 18: 205-9
25. Grange JM. Complications of bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health 1998; 1: 84-8
26. Verbov J. Local skin complications of BCG vaccination. Practitioner 1984; 228: 1069-71
27. Murphy PM, Mayers DL, Brock NF, et al. Cure of bacille Calmette-Guérin vaccination abscesses with erythromycin. Rev Infect Dis 1989; 11: 335-7
28. Raton JA, Pocheville I, Vincente JM, et al. Disseminated bacillus Calmette-Guérin infection in an HIV-infected child: a case with cutaneous lesions. Pediatr Dermatol 1997; 14: 365-8
29. Talbot EA, Perkins MD, Silva SFM, et al. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis 1997; 24: 1139-46
30. McKenzie RH, Roux P. Disseminated BCG infection following bone marrow transplantation for X-linked severe combined immunodeficiency. Pediatr Der-matol 2000; 17: 208-12
31. Gonzales B, Moreno S, Burdach R, et al. Clinical presentations of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J 1989; 8: 201-6
32. Fang JW, Ko BM, Wilson JA. BCG vaccination scars: incidence and acceptance amongst British high-school children. Child Care Health Dev 1993; 19: 37-43
33. Lawrence CM, Summerly ME. Keloid formation after BCG vaccination. Practitioner 1982; 226: 326-8
34. Magnon R, DeVillez RL. Disseminated cutaneous granulomas from BCG therapy. Arch Dermatol 1980; 116: 355
35. Lewis K, Jordan SC, Cherry JD, et al. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine-specific antigens. J Pediatr 1986; 109: 1009-12
36. Dogliotti M. Erythema multiforme: an unusual reaction to BCG vaccination. South Afr Med J 1980; 57: 332-4
37. Tschen EH, Jessen RT, Robertson G, et al. Erythema multiforme as a complication of BCG scarification technique. Arch Dermatol 1979; 115: 614-5
38. Cheson B. BCG therapy and urticaria. Ann Intern Med 1975; 82: 738-9
39. Fauquert JL, Tridon A, Labbé A, et al. Réaction anaphylactoide post-BCG: le rôle du dextran? Rev Fr Allergol Immunol Clin 2001; 41: 412-4
40. Balagon MV, Tan PL, Prestidge R, et al. Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial. Clin Exp Dermatol 2001; 26: 233-41
41. Park YM, Kang H, Cho SH, et al. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol 1999; 41: 262-4
42. Dostrovsky A, Sagher F. Dermatologic complications of BCG vacinnation. Br J Dermatol 1963; 75: 181-92
43. Stewart EJ, James MP. Lupus vulgaris-like reaction following BCG vaccination. Clin Exp Dermatol 1996; 21: 232-4
44. Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to bacille Calmette-Guerin vaccination with multipuncture method. Tuber Lung Dis 1996; 77: 269-73
45. Radeff B, Harms M. Acute febrile neutrophilic dermatosis (Sweet's syndrome) following BCG vaccination. Acta Dermatol Venereol 1986; 66: 357-8
46. Kothari SS. Aetiopathogenesis of Takayasu's arteritis and BCG vaccination: the missing link? Med Hypotheses 1995; 45: 227-30
47. Lee SM, Hann SK, Chun SI, et al. An unusual form of skin tuberculosis following BCG vaccination. J Dermatol 1994; 21: 106-10
48. Houcke-Bruge C, Delaporte E, Catteau B, et al. Granulome annulaire après vaccination par le BCG vaccination. Ann Dermatol Venereol 2001; 128: 541-4
49. Rennels MR, Deloria MA, Pichichero ME, et al. Lack of consistent relationship between quantity of aluminium in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 2002; 20: 544-7
50. Pembroke AC, Marten RH. Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin Exp Dermatol 1979; 4: 345-8
51. Blennow M, Granstrom M, Strandell A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 1994; 12: 427-30
52. Ponvert C, Scheinmann P, Karila C, et al. L'allergie aux vaccins associés chez l'enfant: une étude de 30 cas fondée sur les tests cutanés à lecture immédiate, semi retardée, et retardée, sur les dosages des anticoprs spécifiques et sur l'injection de rappel. Rev Fr Allerg Immunol Clin 2001; 41: 701-11
53. Poley GE, Slater JE. Drug and vaccine allergy. Immunol Allergy Clin N Am 1999; 19: 409-22
54. Johnson C, Walls RS, Ruwoldt A. Delayed type hypersensitivity to tetanus toxoid in man. In vivo and in vitro studies. Pathology 1983; 15: 369-72
55. Griffith RD, Miller III OF. Erythema multiforme following diphtheria and tetanus toxoid vaccination. J Am Acad Dermatol 1988; 19: 758-9
56. Baraff LJ, Manclark CR, Cherry JD, et al. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J 1989; 8: 502-7
57. Fawcett HA, Smith NP. Injection-site granuloma due to aluminum. Arch Dermatol 1984; 120: 1318-22
58. Slater DN, Underwood JCE, Durrant TE, et al. Aluminium hydroxide granulomas: light and electron microscopy studies and X-ray microanalysis. Br J Dermatol 1982; 107: 103-8
59. Nagore E, Martinez-Escribano JA, Tata A, et al. Subcutaneous nodules following treatments with aluminium-containing allergen extracts. Eur J Dermatol 2001; 11: 138-40
60. Akosa AB, Ali MH, Khoo CT, et al. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology 1990; 16: 589-93
61. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001; 44 Suppl. 2: 348-50
62. Venning VA, Wojnarowska F. Induced bullous pemphigoid. Br J Dermatol 1995; 132: 831-2
63. Fournier B, Descamps V, Bouscarat F, et al. Bullous pemphigoid induced by vaccination. Br J Dermatol 1996; 135: 144-61
64. Bellaney GJ, Rycroft RJ. Pemphigus vulgaris following a hyperimmune response to typhoid booster. Clin Exp Dermatol 1996; 21: 434-6
65. Leung AKC. Anaphylaxis to DPT vaccine [letter]. J R Soc Med 1985; 78: 175
66. Piletta PA, Pasche-Koo F, Saurat JH, et al. Immediate local reaction to tetanus toxoid booster. Allergy 1997; 52: 676-7
67. Kwittken P, Rosen S, Sweinberg S. MMR vaccine and neomycin allergy. Am J Dis Child 1993; 147: 128-9
68. Beck S, Williams LW, Shirrell MA, et al. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics 1991; 88: 913-7
69. Fasano MB, Wood RA, Cooke SK, et al. Egg hypersensitivity and adverse reactions to measles, mumps and rubella vaccine. J Pediatr 1992; 120: 878-81
70. Vourga V, Tapratzi P, Panayatopoulou K. Measles-mumps-rubella vaccine (MMR) in egg-allergic children [letter]. Allergy 1997; 52: 96
71. Aukrust L, Almeland TL, Refsum D, et al. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Allergy 1980; 35: 581-7
72. Buntain WL, Missall SR. Local subcutaneous atrophy following measles, mumps, and rubella vaccination [letter]. Am J Dis Child 1976; 130: 335
73. Aickin R, Hill D, Kemp A. Measles immunisation in children with allergy to egg. BMJ 1994; 409: 223-5
74. Bellanti JA, Fishman HJ, Wientzen RL. Adverse reactions to vaccines. Immunol Allergy Clin N Am 1987; 7: 423-45
75. Ponvert C, Ardelean-Jaby D, Colin-Gorski AM, et al. Anaphylaxis to the 23-valent pneumococcal vaccine in children: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine 2001; 19: 4588-91
76. Maddos PR, Motley RJ. Sweet's syndrome: a severe complication of pneumococcal vaccination following emergency splenectomy. Br J Surg 1990; 77: 809-10
77. Furth SL, Fivush BA. Varicella vaccination in pediatric kidney transplant candidates. Pediatr Transplant 2002; 6: 97-100
78. Kumagai T, Yamanaka T, Wataya Y, et al. Gelatin-specific humoral and cellular immune responses in children with immediate and non-immediate type reactions to live measles, mumps, rubella and varicella vaccines. J Allergy Clin Immunol 1997; 30: 1430-5
79. Anonymous. Varicella vaccine. Med Lett Drugs Ther 1995; 37: 55-7
80. LaRussa P, Steinberg SP, Shapiro E, et al. Viral strain identification in varicella vaccinees with disseminated rashes. Pediatr Infect Dis J 2000; 19: 1037-9
81. Liang MG, Heidelberg KA, Jacobson RM. et al. Herpes zoster after varicella immunization. J Am Acad Dermatol 1998; 38: 761-3
82. Kamiya H, Ito M. Update on varicella vaccine. Curr Opin Pediatr 1999; 11: 3-8
83. Gerecitano J, Friedman-Kien A, Chazen GD. Allergic reaction to varicella vaccine. Ann Intern Med 1997; 126: 833-4
84. McMahon BJ, Helminiak C, Wainwright RB, et al. Frequency of adverse reactions to hepatitis B vaccine in 43618 persons. Am J Med 1992; 91: 254-5
85. Wolf F, Grezard P, Berard F, et al. Generalized granuloma annulare and hepatitis B vaccination. Eur J Dermatol 1998; 8: 435-6
86. Schmutz JL, Posth M, Granel F, et al. Localized scleroderma after hepatitis B vaccination [in French: letter]. Presse Med 2000; 29 (19): 1046
87. Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ 1990; 301: 345
88. De Keyser F, Naeyaert JM, Hindryckx P, et al. Immune-mediated pathology following hepatitis B vaccination: two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000; 18: 81-5
89. Barbaud A, Trechot P, Reichert-Penetrat S, et al. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol 1998; 139: 925-6
90. Lohiya G. Asthma and urticaria after hepatitis B vaccination [letter]. West J Med 1987; 147: 341
91. Di Lernia V, Lo Scocco G, Bisighini G. Erythema multiforme following hepatitis B vaccine. Pediatr Dermatol 1994; 11: 363-4
92. Wakeel RA, White MI. Erythema multiforme associated with hepatitis B vaccine. Br J Dermatol 1992; 126: 94-5
93. Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Eng J Med 1989; 321: 1198-9
94. Castresana-Ilsa CJ, Herrera-Martinez G, Vega-Molina J. Erythema nodosum and Takayashu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol 1993; 20: 1417-8
95. Rabaud C, Barbaud A, Trechot P. First case of erythermalgia related to hepatitis B vaccination. J Rheumatol 1999; 26: 233-4
96. Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA 1997; 278: 1176-8
97. Sepkowitz S. Hair loss after immunization. JAMA 1998; 279: 117-8
98. Niu MT, Davis DM, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 1996; 15: 771-6
99. Hurwitz S. Clinical pediatric dermatology. Philadelphia (PA): WB Saunders Co, 1981: 366
100. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-33
101. Finielz P, Lam-Kam-Sang LF, Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 1998; 13: 2420-1
102. Le Hello C, Cohen P, Bousser MG, et al. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999; 26: 191-4
103. Bani-Sadr F, Gueit I, Humbert G. Vasculitis related to hepatitis A vaccination. Clin Infect Dis 1996; 22: 596
104. Poulton JK, Kauffman CL, Lutz LL, et al. Solitary mastocytoma arising at a hepatitis B vaccination site. Cutis 1999; 63: 37-40
105. Daoud MS, Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol 1997; 36: 779-80
106. Skowron F, Grezard P, Berard F, et al. Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis 1998; 39: 135-6
107. Naleway AL, Belongia EA, Greenlee RT, et al. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 2003; 139: 1-7
108. Anonymous. Smallpox vaccination and eczema. Med J Aust 1976; 2: 620-1
109. Mintz L. Recurrent herpes simplex infection at a smallpox vaccination site. JAMA 1982; 247: 2704-5
110. Slater DN, Parsons MA, Fussey IV. Malignant fibrous histiocytoma arising in a smallpox vaccination scar. Br J Dermatol 1981; 105: 215-7
111. Rich JD, Shesol BF, Horne III DW. Basal cell carcinoma arising in a smallpox vaccination site. J Clin Pathol 1980; 33: 134-5
112. Castrow FF, Williams TE. Basal-cell epithelioma occurring in a smallpox vaccination scar. J Dermatol Surg 1976; 2: 151-2
113. Mignogna MD, Muzio LL, Ruocco E. Pemphigus induction by influenza vaccination [letter]. Int J Dermatol 2000; 39: 800
114. Downs AM, Lear JT, Bower CP, et al. Does influenza vaccination induce bullous pemphigoid?: a report of four cases [letter]. Br J Dermatol 1998; 138: 363
115. Schmutz JL, Barbaud A, Trechot P. Does influenza vaccination induce bullous pemphigoid? [in French] Ann Derm Venereol 1999; 126 (10): 765
116. Fournier B, Descamps V, Bouscarat F, et al. Bullous pemphigoid induced by vaccination. Br J Dermatol 1996; 135: 153-4
117. Cambiaghi S, Scarabelli G, Pistritto G, et al. Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology 1995; 191: 340-1
118. Confino I, Passwell JH, Padeh S. Erythromelalgia following influenza vaccine in a child. Clin Exp Rheumatol 1997; 15: 111-3
119. Gavaghan T, Webber CK. Severe systemic vasculitic syndrome post influenza vaccination [letter]. Aust N Z J Med 1993; 23: 220
120. Kelsall JT, Chalmers A, Sherlock CH, et al. Microscopic polyangiitis after influenza vaccination. J Rheumatol 1997; 24: 1198-202